Enanta Pharmaceuticals Inc (ENTA)

Cost of Revenue

$1.21M

TTM · Period ending: · USD

ENTA logo

ENTA Cost of Revenue

Latest reported$1.21M
ENTA TTM Cost of Revenue ($0.00 → $1.21M)
High-resolution chart · PNG

ENTA cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Enanta Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
1,209,000
1,209,000
0
0
0
0
0
0
0
0
540,000
1,051,000
1,706,000
2,422,000
1,882,000
1,371,000
716,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.